262 related articles for article (PubMed ID: 28497863)
21. The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.
Miller DC; Whittington KB; Brand DD; Hasty KA; Rosloniec EF
Arthritis Res Ther; 2016 Jan; 18():8. PubMed ID: 26757712
[TBL] [Abstract][Full Text] [Related]
22. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
Lu Y; Schneider H; Rudd CE
Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
[TBL] [Abstract][Full Text] [Related]
23. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells.
Yamada H; Dzhambazov B; Bockermann R; Blom T; Holmdahl R
J Immunol; 2004 Oct; 173(7):4729-35. PubMed ID: 15383610
[TBL] [Abstract][Full Text] [Related]
24. Membrane-bound Dickkopf-1 in Foxp3
Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
[TBL] [Abstract][Full Text] [Related]
25. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
26. Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
Klocke K; Sakaguchi S; Holmdahl R; Wing K
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2383-92. PubMed ID: 27071130
[TBL] [Abstract][Full Text] [Related]
27. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
Jain N; Nguyen H; Chambers C; Kang J
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1524-8. PubMed ID: 20080649
[TBL] [Abstract][Full Text] [Related]
28. Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming.
Matheu MP; Othy S; Greenberg ML; Dong TX; Schuijs M; Deswarte K; Hammad H; Lambrecht BN; Parker I; Cahalan MD
Nat Commun; 2015 Feb; 6():6219. PubMed ID: 25653051
[TBL] [Abstract][Full Text] [Related]
29. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.
Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
J Immunol; 2013 Jun; 190(11):5382-91. PubMed ID: 23630354
[TBL] [Abstract][Full Text] [Related]
30. Retinal attenuates inflammatory arthritis by reciprocal regulation of IL-17-producing T cells and Foxp3(+) regulatory T cells and the inhibition of osteoclastogenesis.
Park MK; Jhun JY; Lee SY; Oh HJ; Park MJ; Byun JK; Yoon BY; Park EM; Lee DG; Kwok SK; Park SH; Kim HY; Cho ML
Immunol Lett; 2012; 148(1):59-68. PubMed ID: 22841964
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
32. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
[TBL] [Abstract][Full Text] [Related]
33. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner.
Guereschi MG; Araujo LP; Maricato JT; Takenaka MC; Nascimento VM; Vivanco BC; Reis VO; Keller AC; Brum PC; Basso AS
Eur J Immunol; 2013 Apr; 43(4):1001-12. PubMed ID: 23436577
[TBL] [Abstract][Full Text] [Related]
34. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
[TBL] [Abstract][Full Text] [Related]
35. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
36. Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis.
Eneljung T; Tengvall S; Jirholt P; Henningsson L; Holmdahl R; Gustafsson K; Gjertsson I
Clin Dev Immunol; 2013; 2013():345092. PubMed ID: 24371448
[TBL] [Abstract][Full Text] [Related]
37. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
[TBL] [Abstract][Full Text] [Related]
38. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
39. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
40. Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis.
Andersson SE; Eneljung T; Tengvall S; Jirholt P; Stern A; Henningsson L; Liang B; Thorarinsdottir K; Kihlberg J; Holmdahl R; Mårtensson IL; Gustafsson K; Gjertsson I
Arthritis Res Ther; 2016 Jun; 18(1):140. PubMed ID: 27301320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
